Oct 16 (Reuters) - Drugstore chain Rite Aid is the latest U.S. company to seek bankruptcy protection following pressure from lawsuits alleging that they helped fuel the opioid crisis. Opioid drugs have been one of the major causes of the more than one million deaths since 1999 tied to drug overdose, according to data from U.S. Centers for Disease Control and Prevention. Litigation against drugmakers, pharmacies and distributors, claiming that drugmakers downplayed the risks of opioids and that distributors and pharmacies failed to prevent them from being diverted to the illegal market has resulted in more than $50 billion in total settlements. Here is a list of companies forced to file for bankruptcy protection, mainly due to U.S. opioid lawsuits and settlements. COMPANY BANKRUPTCY DETAILS FILING DATE RITE Aid October 2023 Rite Aid files for bankruptcy protection and says it will close underperforming stores. The company adds it has received a commitment for $3.45 billion from some lenders to stay afloat during the bankruptcy process. Mallinckrodt August 2023 Ireland-based drugmaker files for its second bankruptcy in the United States in a move that reduced $1 billion from what it owes to victims of the U.S. opioid crisis. Endo International August 2022 U.S. drugmaker files for bankruptcy seeking to settle thousands of lawsuits over its alleged role in the opioid epidemic. Rochester Drug March 2020 Drug distributor files for bankruptcy, nearly Co-operative a year after it became the first pharmaceutical distributor to be criminally charged in relation to the opioid crisis. Purdue Pharma September OxyContin maker files for bankruptcy as part 2019 of proposed $10 billion settlement for its creditors, individual victims of addiction and others who sued the company. The US Supreme Court halts settlement in August after government challenges its legality amid concerns it would shield its wealthy owners, the Sackler family. Insys Therapeutics June 2019 The drugmaker files for bankruptcy protection amid mounting expenses driven by a U.S. Justice Department probe into claims it paid doctors bribes to prescribe a powerful opioid medication. (Reporting by Pratik Jain and Leroy Leo in Bengaluru; Editing by Arun Koyyur)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.145 USD | +11.54% | +11.54% | -33.76% |
04-11 | First Motion for Exclusivity Period Extension Approved For Rite Aid Corporation | CI |
04-09 | Motion for Asset Sale Filed by Rite Aid Corporation | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
0.145 USD | +11.54% | +11.54% | 7.15M | ||
0.0006 USD | 0.00% | 0.00% | 2.35M | ||
1st Jan change | Capi. | |
---|---|---|
-33.76% | 7.15M | |
-11.02% | 8.9B | |
+35.27% | 1.42B | |
+10.50% | 434M | |
-1.50% | 266M | |
+13.33% | 226M | |
-44.91% | 86.07M | |
+25.01% | 62.31M |
- Stock Market
- Equities
- RADCQ Stock
- News Rite Aid Corporation
- Rite Aid joins companies going bankrupt amid opioid litigation